
The OPuS One Study: Advancing Clinical Evidence in the Treatment of Bone Metastases
In this episode, IOL Radio speaks with Jason Levy, MD, lead investigator of OPuS One, a study done on the outcomes of the first 100 patients treated with the OsteoCool™ System. The OsteoCool™ RF Ablat...
1 Jan 202323min

NuView Life Science`s VPAC1 Technology
In this episode of IOL Radio, we speak with Dr Albert DeNittis, a radiation oncologist at Lankenau Cancer Center in Wynnewood, Pennsylvania. Dr Dennitis is here to discuss NuView Life Science’s VPAC1,...
1 Jan 202324min

The LEGACY Study Confirms TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepa...
14 Des 202239min



















